Atlas Trials

Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection

Clinical trial NCT01742429 · COMPLETED

Trial details

NCT number
NCT01742429
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cure Rate of Helicobacter Pylori Infection
Start date
2012-11-01
Primary completion
2013-04-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.